Your browser doesn't support javascript.
loading
Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy.
Ramchand, Jay; Sampaio Rodrigues, Thalys; Yudi, Matias B; Burrell, Louise M.
Affiliation
  • Ramchand J; Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.
  • Sampaio Rodrigues T; Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia.
  • Yudi MB; Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.
  • Burrell LM; Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.
Heart ; 104(23): 1985, 2018 12.
Article in En | MEDLINE | ID: mdl-30429268
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiomyopathy, Hypertrophic / Angiotensins Limits: Humans Language: En Journal: Heart Journal subject: CARDIOLOGIA Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiomyopathy, Hypertrophic / Angiotensins Limits: Humans Language: En Journal: Heart Journal subject: CARDIOLOGIA Year: 2018 Document type: Article Affiliation country: Country of publication: